Staloral® is a sublingual solution of allergen extract, it addresses the underlying cause of allergy.
Staloral® is indicated in the treatment of IgE-mediated Allergic Rhinitis & Allergic Asthma with or without conjunctivitis in adults, adolescents, and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive Skin Prick Test or Blood specific IgE test.
Box Contents:
1 vial of 10 IR/ml (Blue vial).
2 vials of 100 IR/ml (Red vials).
Indications:
Type I allergies (Gell and Coombs classification) mainly involving rhinitis, conjunctivitis, rhino conjunctivitis or asthma (mild to moderate) of a seasonal or perennial nature, in children, adolescents and adults.
Product Information:
10 ml vials with a 100 μg dosing pump specifically developed for sublingual administration.
Staloral® offers a variety of dose escalation schedules (slow, standard and ultra-rush), with vials from 10 to 300 IR/mL supplied with dosing pumps.
Recommended treatment duration is 3 years.
How to Use:
The solution is to be placed under the tongue for 2 minutes then swallowed
For build-up phase and dose escalation procedure, please refer to your doctor’s instructions.
Warnings & Precautions:
For patients requiring SLIT, symptoms must be controlled prior to therapy by means of suitable treatment where necessary.
Standard symptomatic treatment (corticosteroids, beta-2-mimetics, histamine H1 antagonists) should be available for patients for whom sublingual administration of allergens has been prescribed.
Staloral® is a sublingual solution of allergen extract, it addresses the underlying cause of allergy.
Staloral® is indicated in the treatment of IgE-mediated Allergic Rhinitis & Allergic Asthma with or without conjunctivitis in adults, adolescents, and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive Skin Prick Test or Blood specific IgE test.
Box Contents:
1 vial of 10 IR/ml (Blue vial).
2 vials of 100 IR/ml (Red vials).
Indications:
Type I allergies (Gell and Coombs classification) mainly involving rhinitis, conjunctivitis, rhino conjunctivitis or asthma (mild to moderate) of a seasonal or perennial nature, in children, adolescents and adults.
Product Information:
10 ml vials with a 100 μg dosing pump specifically developed for sublingual administration.
Staloral® offers a variety of dose escalation schedules (slow, standard and ultra-rush), with vials from 10 to 300 IR/mL supplied with dosing pumps.
Recommended treatment duration is 3 years.
How to Use:
The solution is to be placed under the tongue for 2 minutes then swallowed
For build-up phase and dose escalation procedure, please refer to your doctor’s instructions.
Warnings & Precautions:
For patients requiring SLIT, symptoms must be controlled prior to therapy by means of suitable treatment where necessary.
Standard symptomatic treatment (corticosteroids, beta-2-mimetics, histamine H1 antagonists) should be available for patients for whom sublingual administration of allergens has been prescribed.